Connect with us

National

Baboons wreak havoc in drought prone Binga, Hwange

Published

on

BY NOKUTHABA DLAMINI

The Zimbabwe Parks and Wildlife Management Authority (Zimparks) says traditional methods to stop baboons from raiding people’s homes in Matabeleland North districts such as Hwange and Binga have become ineffective against the animals that are pushed from their habitat by climate change induced droughts.

Advertisement

A number of residents in Victoria Falls, Binga and Hwange have had their property destroyed by baboons, which break into houses through windows and rooftops while searching for food.

The baboons also attack women and children.

A video shared by a Mpumalanga resident in Hwange that has gone viral on social media shows a troop of baboons ripping apart the rooftop of his house before they gained entry.

Advertisement

Zimparks has since embarked on an exercise to capture the baboons, but its Matabeleland North regional manager Samson Chibaya said it was proving to be a herculean task.

“Baboons are a perennial nuisance in Hwange urban and other areas such as Binga and Victoria Falls,” Chibaya said in an interview.

“They cause damage in hotels, lodges and homes and their behavior includes destruction of property and taking food from kitchens, off the buffets and tables.”

Advertisement

He said it was becoming increasingly difficult to capture the baboons because they now know how to avoid baits.

“Capture and translocation is no longer effective because the baboons no longer come to the baits,” Chibaya said.

“Shooting is also ineffective as the baboons are so elusive and flee once they see armed people in uniform.

Advertisement

“They are (also) territorial, once a troop is wiped out another different one quickly moves in within a week or two.”

Zimparks rangers put the captured baboons in cages before moving them deep into the Hwange National Park around the Sinamatella area.

Mary Mulinde, a Hwange resident, said the situation had gone out of control and urged Zimparks to find better ways of controlling the population of baboons.

Advertisement

“It is so bad because they target children walking to school and snatch their satchels,” Mary Mulinde said.

“They are also targeting houses without anyone inside and they gain entry through windows, doors and rooftops that they would’ve vandalised.

Chibaya attributed the increasing cases of human wildlife conflict in urban areas such as Hwange to droughts caused by climate change and poor solid waste management.

Advertisement

“Poor solid waste management is another factor as baboons are attracted to leftovers food and addible waste,” he added.

“Most raids in residential areas happen where houses are not manned, and sometimes in the presence of children and women.

“Ecologically, most of the areas around towns have no food and fruits for baboons, hence (they) rely on waste from residential area.”

Advertisement

“The problem worsens during the hot and dry season when food availability is less available.

“Baboons generally have a high recruitment rate and do not have a lot of predators to feed on them, hence the high survival rate and a high population density.”

He said Hwange town was surrounded by areas with a high population of wild animals such as the Hwange Colliery Concession, private farms, state land and protected areas under Zimparks and this meant that animals such as baboons would stray into residential areas.

Advertisement

According to a 2019 game census for Hwange National Park and surrounding areas conducted by Wildlife and Environment Zimbabwe, there  was an increase in species such as the chacma baboon, impala and zebra population from 14 882 in 2011 to 22 544 in 2019.

Chibaya urged Hwange residents to assist Zimparks in controlling the baboon population by refraining from giving them food and disposing waste in undesignated areas.

He said alternative ways to control the baboon population was killing the problematic ones through poisoning and tightening security in homes.

Advertisement

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

Tragic attack in Madlambuzi: Five dead as suspected mental patient goes on rampage

Published

on

BY WANDILE TSHUMA 

Police in Madlambuzi, Matabeleland South Province has are a suspected mental patient, Phamani Sibanda, following a violent rampage that left five people dead and two others injured on Wednesday.

Advertisement

According to the police statement, Sibanda (43) allegedly attacked seven people in the village using a Mopani log, a blunt object, and an unknown sharp weapon, targeting anyone who crossed his path.

The victims of this tragic attack have been identified by their next of kin:

Elliot Khupe, 101, a male adult from Bellas Village
Butho Tshuma, 97, a female adult from Bellas Village
Constance Sibanda, 66, a female adult from Bellas Village
Tiffan Surprise Ndlovu, 6, a female juvenile from Bellas Village
Catra Matsika, 72, from Central Village

Advertisement

In addition to the fatalities, two other women, aged 90 and 41, sustained injuries and are currently receiving treatment at Madlambuzi Clinic and Plumtree District Hospital.

The ZRP has underscored the pressing need for community awareness regarding mental health issues. “We implore the public to promptly refer mental patients to medical institutions for treatment and to actively monitor their behavior to prevent such violent incidents,” the statement elaborated. It encouraged community members to report any concerns to the National Complaints Desk at (0242) 703631 or via WhatsApp at 0712 800197, or to approach the nearest police station.

 

Advertisement

Continue Reading

National

US suspends visa processing in Zimbabwe, embassy says

Published

on

BY REUTERS

The United States has stopped processing most visas in Zimbabwe until further notice, its embassy in the capital Harare said on Wednesday, citing unspecified concerns with the government.
“We have paused routine visa services in Harare while we address concerns with the Government of Zimbabwe,” the embassy said in a post on X. It said the move was not a travel ban and that current visas would remain valid.
The government of the Southern African country did not immediately reply to a request for comment.
The pause took effect on August 7, according to a notice on the U.S. State Department’s website, which said it applied to all visa services with the exception of most diplomatic and official visas.
U.S. President Donald Trump’s administration has restricted travel from a number of African countries, saying it is working to prevent visa overstaying and misuse.
Zimbabwe had a visa overstay rate of 10.57% in 2023, according to a U.S. Department of Homeland Security report.
Starting this week, the U.S. will require visa applicants from Zambia and Malawi to pay bonds of up to $15,000 for some visitor visas. The Trump administration has also paused visa processing in Niger.
Harare resident Angella Chirombo said her 18-year-old son had received a scholarship to do his bachelor’s degree at Michigan State University and had been waiting for a visa interview when the pause hit.
“He was supposed to be in school already. I paid for everything else and was waiting for the visa so I could buy tickets,” she told Reuters.
She said other parents were considering booking interviews at other U.S. embassies in Southern Africa, but that she wouldn’t be able to afford the travel.
“Now they are saying we can go to Zambia and Namibia. I don’t even have money right now and I don’t know where to get this money. They are so many students that have been affected.”

Continue Reading

National

Landmark HIV trial begins in Zimbabwe

Published

on

BY PAUL SIXPENCE

ZIMBABWE became the first site for the administration of a new investigational HIV vaccine. The first doses of the IAVI C114 clinical trial were administered in late July 2025 at the Mutala Trust clinical site in Harare, CITE reports.

Advertisement

“This is a landmark moment for South Africa, Zimbabwe, and the continent. It shows the power of true partnership,” said Dr. Tariro Makadzange, clinical trial lead, Mutala Trust.

“We are edging closer to an HIV vaccine, made possible by global collaboration, with clinical trials conducted in Africa, for Africa, and for the world.”

The development of the vaccine is a partnership that brings together Zimbabwe’s Mutala Trust, ReiThera, the Ragon Institute, International AIDS Vaccine Initiative (IAVI) and African researchers who are co-leading every phase of the trial.

Advertisement

In phase one of the trial, the vaccine candidate, Gorilla Adenovirus Vectored HIV Networked Epitopes Vaccine (GRAdHIVNE1) will be administered to 120 adults between the ages of 18 and 50 years including 48 people living with HIV who are virally suppressed on antiretroviral therapy (ART). Besides Zimbabwe, two other clinical trial sites are located in Cape Town and Durban, South Africa.

Trial sites were chosen on the basis of their high HIV burden and to ensure that the vaccine candidate is tested within communities affected by the epidemic.

This phase of the trial will assess the safety and ability of the vaccine candidate to provoke an immune response in the human body in persons living with HIV and those who are HIV negative.

Advertisement

“The IAVI C114 trial is testing a new vaccine candidate known as GRAdHIVNE1. The trial represents the first time this vaccine is being tested in humans and is aimed at assessing the safety of the vaccine and its ability to stimulate the immune system,” said Dr. Vincent Muturi-Kioi, HIV Vaccines Product Development Team Lead, IAVI.

In a statement, IAVI further advised that “trial participants will receive either one or two doses of the investigational vaccine or a placebo and will be monitored over a period of 19 months for safety and immune responses.” Results of the trial are likely to be available in 2027.

In the past, several HIV vaccine trials have been conducted but none proved effective in preventing HIV acquisition. The novelity of this vaccine candidate lies in that, it uses a harmless viral vector to deliver small parts of HIV “derived from critical structural regions of HIV that are less likely to mutate” with an expected likelihood to trigger an immune response.

Advertisement

“GRAdHIVNE1 uses a harmless virus (a vector for the vaccine derived from a non-replicating gorilla adenovirus) to deliver small, conserved parts of HIV (called epitopes) to the body’s immune system. These targets are derived from critical structural regions of HIV that are less likely to mutate, making them good targets for killer T cells in the immune system (CD8+ T cell responses) — a type of immune defense thought to be important for long-term protection against HIV. The viral vector was selected based on its ability to stimulate this type of response. Should the vaccine be successful in stimulating the desired response, it could be tested in future trials to assess its efficacy,” Dr. Vincent Muturi-Kioi further explained.

The initiation of this clinical trial demonstrates the power of partnerships at a time when the world is witnessing funding cuts towards global public health research. The IAVIC114 clinical trial is sponsored by IAVI. The vaccine candidate, GRAdHIVNE1, was developed by ReiThera and the Ragon Institute with funding from the GatesFoundation. African researchers will be leading

SOURCE| CITE

Advertisement

Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage